Similarly, RSK2 gene knock-down with shRNA and chemical inhibition significantly blocked GBM SK748 invasion in transwell assays with epidermal growth factor (EGF) and fibroblast growth factor (FGF) as chemoattractants (Figure 5D). The gene discussed is EGF; the disease is glioblastoma.